XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
2027 Notes
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid in Capital
Additional Paid in Capital
2027 Notes
Additional Paid in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020         22,983,000                  
Beginning balance at Dec. 31, 2020 $ 188,405       $ 459 $ 243,575       $ (46,706)     $ (3,936) $ (4,987)
Treasury stock (in shares) at Dec. 31, 2020                           1,066,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         34,000                  
Issuance of common stock upon the exercise of stock options 409       $ 1 408                
Net issuance of restricted stock awards and restricted stock units (in shares)         87,000                  
Net issuance of restricted stock awards and restricted stock units 265       $ 2 263                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           76,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (3,974)                         $ (3,974)
Stock-based compensation 1,320         1,320                
Foreign currency translation adjustments (302)                       (302)  
Net loss (8,271)                 (8,271)        
Ending balance (in shares) at Mar. 31, 2021         23,104,000                  
Ending balance at Mar. 31, 2021 177,852       $ 462 245,566       (54,977)     (4,238) $ (8,961)
Treasury stock (in shares) at Mar. 31, 2021                           1,142,000
Beginning balance (in shares) at Dec. 31, 2020         22,983,000                  
Beginning balance at Dec. 31, 2020 188,405       $ 459 243,575       (46,706)     (3,936) $ (4,987)
Treasury stock (in shares) at Dec. 31, 2020                           1,066,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Foreign currency translation adjustments (56)                          
Net loss (50,160)                          
Ending balance (in shares) at Sep. 30, 2021         28,017,000                 1,161,000
Ending balance at Sep. 30, 2021 524,681       $ 560 634,895       (96,866)     (3,992) $ (9,916)
Beginning balance (in shares) at Dec. 31, 2020         22,983,000                  
Beginning balance at Dec. 31, 2020 $ 188,405       $ 459 243,575       (46,706)     (3,936) $ (4,987)
Treasury stock (in shares) at Dec. 31, 2020                           1,066,000
Ending balance (in shares) at Dec. 31, 2021 26,924,397       28,095,000                  
Ending balance at Dec. 31, 2021 $ 504,345   $ (80,036) $ 424,309 $ 562 640,937   $ (66,656) $ 574,281 (122,505) $ (13,380) $ (135,885) (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                           1,181,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                          
Beginning balance (in shares) at Mar. 31, 2021         23,104,000                  
Beginning balance at Mar. 31, 2021 $ 177,852       $ 462 245,566       (54,977)     (4,238) $ (8,961)
Treasury stock (in shares) at Mar. 31, 2021                           1,142,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         20,000                  
Issuance of common stock upon the exercise of stock options 209         209                
Net issuance of restricted stock awards and restricted stock units (in shares)         28,000                  
Net issuance of restricted stock awards and restricted stock units 1       $ 1                  
Issuance of common stock for acquisition (in shares)         1,493,000                  
Issuance of common stock for acquisition 108,659       $ 30 108,629                
Issuance of common stock, net of issuance costs (in shares)         2,353,000                  
Issuance of common stock, net of issuance costs 155,687       $ 47 155,640                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           7,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (497)                         $ (497)
Stock-based compensation 4,251         4,251                
Foreign currency translation adjustments 355                       355  
Net loss (9,956)                 (9,956)        
Ending balance (in shares) at Jun. 30, 2021         26,998,000                  
Ending balance at Jun. 30, 2021 436,561       $ 540 514,295       (64,933)     (3,883) $ (9,458)
Treasury stock (in shares) at Jun. 30, 2021                           1,149,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         22,000                  
Issuance of common stock upon the exercise of stock options 200       $ 1 199                
Net issuance of restricted stock awards and restricted stock units (in shares)         15,000                  
Net issuance of restricted stock awards and restricted stock units 0                          
Issuance of common stock for acquisition 1,081         1,081                
Issuance of common stock, net of issuance costs (in shares)         982,000                  
Issuance of common stock, net of issuance costs 52,486 $ 63,068     $ 19 52,467 $ 63,068              
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           12,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (458)                         $ (458)
Stock-based compensation 3,785         3,785                
Foreign currency translation adjustments (109)                       (109)  
Net loss (31,933)                 (31,933)        
Ending balance (in shares) at Sep. 30, 2021         28,017,000                 1,161,000
Ending balance at Sep. 30, 2021 $ 524,681       $ 560 634,895       (96,866)     (3,992) $ (9,916)
Beginning balance (in shares) at Dec. 31, 2021 26,924,397       28,095,000                  
Beginning balance at Dec. 31, 2021 $ 504,345   (80,036) 424,309 $ 562 640,937   (66,656) 574,281 (122,505) (13,380) (135,885) (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                           1,181,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         96,000                  
Issuance of common stock upon the exercise of stock options 813       $ 2 811                
Net issuance of restricted stock awards and restricted stock units (in shares)         88,000                  
Net issuance of restricted stock awards and restricted stock units 1       $ 1                  
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           45,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (2,051)                         $ (2,051)
Stock-based compensation 3,536         3,536                
Foreign currency translation adjustments 512                       512  
Net loss (15,650)                 (15,650)        
Ending balance (in shares) at Mar. 31, 2022         28,279,000                  
Ending balance at Mar. 31, 2022 $ 411,470       $ 565 578,628       (151,535)     (3,192) $ (12,996)
Treasury stock (in shares) at Mar. 31, 2022                           1,226,000
Beginning balance (in shares) at Dec. 31, 2021 26,924,397       28,095,000                  
Beginning balance at Dec. 31, 2021 $ 504,345   $ (80,036) $ 424,309 $ 562 640,937   $ (66,656) $ 574,281 (122,505) $ (13,380) $ (135,885) (3,704) $ (10,945)
Treasury stock (in shares) at Dec. 31, 2021                           1,181,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares) 129,000                          
Foreign currency translation adjustments $ (500)                          
Net loss $ (55,838)                          
Ending balance (in shares) at Sep. 30, 2022 27,283,410       28,529,000                  
Ending balance at Sep. 30, 2022 $ 383,086       $ 569 592,100       (191,723)     (4,204) $ (13,656)
Treasury stock (in shares) at Sep. 30, 2022                           1,247,000
Beginning balance (in shares) at Mar. 31, 2022         28,279,000                  
Beginning balance at Mar. 31, 2022 411,470       $ 565 578,628       (151,535)     (3,192) $ (12,996)
Treasury stock (in shares) at Mar. 31, 2022                           1,226,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         16,000                  
Issuance of common stock upon the exercise of stock options 205         205                
Net issuance of restricted stock awards and restricted stock units (in shares)         36,000                  
Net issuance of restricted stock awards and restricted stock units 0                          
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           12,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (397)                         $ (397)
Stock-based compensation 3,231         3,231                
Foreign currency translation adjustments (161)                       (161)  
Net loss (18,848)                 (18,848)        
Ending balance (in shares) at Jun. 30, 2022         28,331,000                  
Ending balance at Jun. 30, 2022 395,500       $ 565 582,064       (170,383)     (3,353) $ (13,393)
Treasury stock (in shares) at Jun. 30, 2022                           1,238,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon the exercise of stock options (in shares)         17,000                  
Issuance of common stock upon the exercise of stock options 250       $ 1 249                
Net issuance of restricted stock awards and restricted stock units (in shares)         18,000                  
Net issuance of restricted stock awards and restricted stock units 0                          
Issuance of common stock for acquisition (in shares)         163,000                  
Issuance of common stock for acquisition 6,300       $ 3 6,297                
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)                           9,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (263)                         $ (263)
Stock-based compensation 3,490         3,490                
Foreign currency translation adjustments (851)                       (851)  
Net loss $ (21,340)                 (21,340)        
Ending balance (in shares) at Sep. 30, 2022 27,283,410       28,529,000                  
Ending balance at Sep. 30, 2022 $ 383,086       $ 569 $ 592,100       $ (191,723)     $ (4,204) $ (13,656)
Treasury stock (in shares) at Sep. 30, 2022                           1,247,000